# DABIGATRAN ETEXILATE

NDC: 59651-975
Generic name: DABIGATRAN ETEXILATE
Labeler / Manufacturer: Aurobindo Pharma Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20250514

FDA application: ANDA208039

## Active ingredients

- DABIGATRAN ETEXILATE MESYLATE: 150 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"59651-975"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=59651-975
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5b196b1f-408e-4615-b980-9f822adff835